Back to 
JPMorgan Chase & Co.
JPMorgan Chase & Co.
EVMN
3 quarters
Position history for JPMorgan Chase & Co.'s holdings in Evommune, Inc.
Yes. JPMorgan Chase holds 1,553,132 shares of EVMN (Evommune), worth $23.4M, as of its Q2 2026 13F filing. It increased the position by 93,712 shares (+6.4%) from Q1 2026. JPMorgan Chase has held EVMN in every 13F on record since Q4 2025, 3 quarterly filings.
Current Value
$23.4M
Current Shares
1.6M
Total Value Change
+$966,252
Total Shares Change
+244,231
Quarter-by-Quarter History
Other major holders of EVMN: RA Capital Management, L.P., RTW Investments, LP, T. Rowe Price Associates, Inc.